Literature DB >> 12514784

Portal lymphocytic infiltrate in alcoholic liver disease.

Magali Colombat1, Frédéric Charlotte, Vlad Ratziu, Thierry Poynard.   

Abstract

The aim of this study was to estimate the frequency of lymphocytic portal infiltrate in human alcoholic liver disease and to determine whether it was correlated with liver injury. This retrospective study included 200 consecutive patients referred between February 1996 and March 2001 to the Service Central d'Hépato-Gastroentérologie at Groupe Hospitalier Pitié-Salpêtrière Hospital, Paris, France. The inclusions criteria were as follows: (1) daily alcohol consumption greater than 40 g; (2) appropriate serological exclusion of B and C viral hepatitis; and (3) available liver biopsy specimen. Autoimmune hepatitis was excluded in all patients with the aid of a consensus scoring system. Forty percent of the patients had a predominantly lymphocytic portal infiltrate. On stepwise logistic regression of the predictive value of the 5 variables (gender, age, daily alcohol consumption, steatosis, and portal and septal fibrosis index), only 2 statistically independent predictors of predominant lymphocytic portal infiltrate were identified: portal and septal fibrosis index (P <.05) and age (P <.05). In conclusion, predominantly portal lymphocytic infiltrate occurs frequently in alcoholic liver disease, even in patients without serological markers of B and C viral hepatitis. Moreover, after adjustment for age, portal and septal fibrosis index remains significantly associated with the presence of a predominantly lymphocytic portal infiltrate. These results suggest that lymphocytes may play a role in the pathogenesis of alcohol-induced liver fibrosis. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12514784     DOI: 10.1053/hupa.2002.129414

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Pathogenesis of alcoholic hepatitis: Role of inflammatory signaling and oxidative stress.

Authors:  Sarat C Jampana; Rashid Khan
Journal:  World J Hepatol       Date:  2011-05-27

2.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Aynur Unalp; Cynthia E Behling; Joel E Lavine; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 3.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

Review 4.  Melatonin role preventing steatohepatitis and improving liver transplantation results.

Authors:  Eduardo Esteban-Zubero; Francisco Agustín García-Gil; Laura López-Pingarrón; Moisés Alejandro Alatorre-Jiménez; José Manuel Ramírez; Dun-Xian Tan; José Joaquín García; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

5.  Immune mechanisms in alcoholic liver disease.

Authors:  Emanuele Albano; Matteo Vidali
Journal:  Genes Nutr       Date:  2009-10-07       Impact factor: 5.523

6.  Serum soluble major histocompatibility complex class I-related chain A/B expression in patients with alcoholic liver disease in Hainan Li community.

Authors:  Xiaobin Wei; Biqiong Ren; Danqin Lin; Bin Luo; Xianxian Fu; Chunyun Li; Huan Xia; Xi Xiao; Ping Yu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy.

Authors:  Toshihiro Kawaguchi; Tatsuya Ide; Reiichiro Kondo; Yoriko Nomura; Teruko Arinaga-Hino; Reiichiro Kuwahara; Keisuke Amano; Tomoya Sano; Jun Akiba; Koichi Ohshima; Hirohisa Yano; Takuji Torimura
Journal:  Exp Ther Med       Date:  2019-09-18       Impact factor: 2.447

8.  Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.

Authors:  Stephanie C Burke Schinkel; Lorna Carrasco-Medina; Curtis L Cooper; Angela M Crawley
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.